Cover image of the article: Metabolic Syndrome and Inflammatory Biomarkers in Adults: A Population-Based Survey in Western Region of Iran

Image Credit:Int Cardiovasc Res J

Metabolic Syndrome and Inflammatory Biomarkers in Adults: A Population-Based Survey in Western Region of Iran

Authors

Ali Maleki1, Negin Rashidi2, Hamidreza Aghaei Meybodi3, Mahdi Montazeri4,*, Mohammad Montazeri5, Farid Falsafi6, Reza Ghanavati1, Saeid Forughi6, Farshid Alyari6

Abstract

Background: There is evidence that inflammation may be involved in pathogenesis of MetS. Inflammatory biomarkers are moving to the forefront as the potent predictors of MetS.

Objectives: The present study aimed to evaluate the association between MetS and some inflammatory biomarkers.

Patients and Methods: This community-based cross-sectional study was conducted on 800 subjects aged above 35 years selected through random sampling in Borujerd (west of Iran) from 2011 to 2013. MetS was defined based on ATP III criteria and the subjects were divided into two groups (MetS and non-MetS groups). Waist circumference and Body Mass Index (BMI) were calculated. In addition, blood samples were taken and C-Reactive Protein (CRP), lipid profile, Fasting Blood Sugar (FBS), and Bleeding Time (BT) were measured. Then, the correlations between MetS and the above-mentioned variables were estimated. After all, the data were entered into the SPSS statistical software (v. 17) and analyzed using T-test, chi-square, median test, and spearman’s rank correlation.

Results: In this study, 344 subjects (43%) met the ATP III criteria. The results showed a significant difference between MetS and non-MetS groups regarding BMI, white blood cell, total cholesterol, LDL, platelet, and high-sensitivity CPR (hs-CRP) (P < 0.0001, P = 0.040, P < 0.0001, P < 0.0001, and P = 0.045, respectively). Besides, waist circumference, Triglyceride (TG), FBS, and systolic and diastolic blood pressure were significantly higher, while HDL was significantly lower in the MetS group (P < 0.0001).

Conclusions:: The incidence rate of MetS in our survey was higher compared to the previous reports. In addition, this incidence rate was higher in females in comparison to males. The results also showed a significant correlation between inflammatory biomarkers and MetS and that the higher levels of hs-CRP were associated with higher rate of MetS.

Highlights

How to Cite:Maleki A, Rashidi N, Aghaei Meybodi H, Montazeri M, Montazeri M, et al. Metabolic Syndrome and Inflammatory Biomarkers in Adults: A Population-Based Survey in Western Region of Iran. Int Cardiovasc Res J. 2017;8(4):e11679. doi:

Fulltext

The full text is available in PDF.

References

  • 1.
    The references are available in PDF.

Copyright

© 2017, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.

Similar Articles

28
Aug
2022
Inflammatory Markers and Atherogenic Coefficient: Early Markers of Metabolic Syndrome

Inflammatory Markers and Atherogenic Coefficient: Early Markers of Metabolic Syndrome

Marjan Mahdavi-Roshan,
Nargeskhatoon Shoaibinobarian,
Morvarid Noormohammadi,
Aboozar Fakhr Mousavi,
Amir Savar Rakhsh,
Arsalan Salari
,et al.

Mahdavi-Roshan M, Shoaibinobarian N, Noormohammadi M, Fakhr Mousavi A, Savar Rakhsh A, et al. Inflammatory Markers and Atherogenic Coefficient: Early Markers of Metabolic Syndrome. Int J Endocrinol Metab. 2022;20(4):e127445. doi: https://doi.org/10.5812/ijem-127445

21
Dec
2012
Number of Components of the Metabolic Syndrome; Smoking and Inflammatory Markers

Number of Components of the Metabolic Syndrome; Smoking and Inflammatory Markers

Tomoyuki Kawada,
Toshiaki Otsuka,
Tokiomi Endo,
Yoichi Kon

Kawada T, Otsuka T, Endo T, Kon Y. Number of Components of the Metabolic Syndrome; Smoking and Inflammatory Markers. Int J Endocrinol Metab. 2012;11(1):. doi: https://doi.org/10.5812/ijem.8403

16
Nov
2021
Prevalence of Metabolic Syndrome and Its Determinants in the Middle-aged and Elderly Population in A Southern Coastal Region, Iran (the PERSIAN Cohort Study): A Cross-sectional Study

Prevalence of Metabolic Syndrome and Its Determinants in the Middle-aged and Elderly Population in A Southern Coastal Region, Iran (the PERSIAN Cohort Study): A Cross-sectional Study

Ghazal Zoghi,
Azim Nejatizadeh,
Mehdi Shahmoradi,
Zahra Ghaemmaghami,
Masoumeh Kheirandish

Zoghi G, Nejatizadeh A, Shahmoradi M, Ghaemmaghami Z, Kheirandish M. Prevalence of Metabolic Syndrome and Its Determinants in the Middle-aged and Elderly Population in A Southern Coastal Region, Iran (the PERSIAN Cohort Study): A Cross-sectional Study. Shiraz E-Med J. 2022;23(3):e116838. doi: https://doi.org/10.5812/semj.116838

27
Feb
2019
Relationships Between Various Components of Metabolic Syndrome and Chronic Kidney Disease in Shiraz, Iran

Relationships Between Various Components of Metabolic Syndrome and Chronic Kidney Disease in Shiraz, Iran

Marzieh Bakhshayeshkaram,
Jamshid Roozbeh,
Seyed Taghi Heidari,
Behnam Honarvar,
Mohammad Hossein Dabbaghmanesh,
Kamran B. Lankarani

Bakhshayeshkaram M, Roozbeh J, Heidari ST, Honarvar B, Dabbaghmanesh MH, et al. Relationships Between Various Components of Metabolic Syndrome and Chronic Kidney Disease in Shiraz, Iran. Int J Endocrinol Metab. 2019;17(2):e81822. doi: https://doi.org/10.5812/ijem.81822

1
Oct
2013
Insulin-Related Biomarkers to Predict the Risk of Metabolic Syndrome

Insulin-Related Biomarkers to Predict the Risk of Metabolic Syndrome

Tomoyuki Kawada

Kawada T. Insulin-Related Biomarkers to Predict the Risk of Metabolic Syndrome. Int J Endocrinol Metab. 2013;11(4):e10418. doi: https://doi.org/10.5812/ijem.10418

More by these authors

Ali MalekiPubMedScholar
Negin RashidiPubMedScholar
Hamidreza Aghaei MeybodiPubMedScholar
Mahdi MontazeriPubMedScholar
Mohammad MontazeriPubMedScholar
Farid FalsafiPubMedScholar
Reza GhanavatiPubMedScholar
Saeid ForughiPubMedScholar
Farshid AlyariPubMedScholar
Share
Cited by
Metrics